RWE Specialist, Real World Evidence, CTS CONEXTS, Novartis Pharmaceuticals UK Ltd, London, W12 7FQ, UK.
RWE Scientific Data Analyst, Real World Evidence, Novartis Healthcare Private Limited, Salarpuria-Sattva Knowledge City, Raidurg, Rangareddy District, Madhapur/Hyderabad, 500081, Telangana.
J Comp Eff Res. 2022 Aug;11(11):815-828. doi: 10.2217/cer-2022-0059. Epub 2022 Jun 14.
To analyze the impact of the COVID-19 pandemic on US healthcare resource utilization. Optum claims data were used to compare all-cause healthcare visits and healthcare spending for selected diseases between the prepandemic and pandemic periods. Telemedicine use was only assessed for the pandemic period owing to data availability. During the first wave of the pandemic, all-cause healthcare visits across all selected disease areas displayed a rapid decline compared with the prepandemic period, followed by a period of recovery. A reduction in outpatient and home healthcare spending was observed, whereas inpatient and prescription spending increased. Changes in healthcare resource utilization trends were observed during the pandemic. The magnitude of these changes can inform subsequent studies that utilize COVID-19-era data.
分析 COVID-19 大流行对美国医疗资源利用的影响。使用 Optum 索赔数据比较大流行前和大流行期间选定疾病的全因医疗就诊次数和医疗支出。由于数据可用性，仅在大流行期间评估远程医疗的使用情况。在大流行的第一波期间，与大流行前时期相比，所有选定疾病领域的全因医疗就诊次数迅速下降，随后出现恢复阶段。观察到门诊和家庭医疗保健支出减少，而住院和处方支出增加。大流行期间观察到医疗资源利用趋势的变化。这些变化的幅度可以为后续使用 COVID-19 时代数据的研究提供信息。
